Results 11 to 20 of about 989,789 (251)

Meta-analysis of the efficacy and adverse drug reactions of adrenergic alpha-antagonists in treating children with ureteral calculi [PDF]

Frontiers in Pediatrics, 2023
This meta-analysis investigated the efficacy and adverse drug reactions (ADRs) of three different adrenergic alpha-antagonists during the treatment of pediatric ureteral stones.
Qing-Hua Xia
exaly   +6 more sources

Do adrenergic alpha‐antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta‐analysis [PDF]

ESC Heart Failure, 2022
Due to concerns regarding neurohormonal activation and fluid retention, adrenergic alpha‐1 receptor antagonists (A1Bs) are generally avoided in the setting of heart disease, namely, symptomatic heart failure (HF) with reduced ejection fraction (HFrEF ...
José Pedro Sousa, Diogo Mendonça, Rogério Teixeira, Lino Gonçalves   +3 more
doaj   +4 more sources

Persistent bothersome urinary frequency following stereotactic body radiation therapy for clinically localized prostate cancer: rationale for prophylactic β3-agonist in men with elevated baseline international prostate symptom scores [PDF]

Frontiers in Oncology
IntroductionStereotactic body radiation therapy (SBRT) for clinically localized prostate cancer has been associated with prolonged acute obstructive and irritative lower urinary tract symptoms (LUTS).
Jennifer Zack, Min Ji Koh, Emily Lindbloom, Timothy O’Connor, Kelly Gaudian, Alan Zwart, Malika Danner, Deepak Kumar, Simeng Suy, Ryan Hankins, Sean Collins   +10 more
doaj   +2 more sources

Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection

eLife, 2021
In severe viral pneumonia, including Coronavirus disease 2019 (COVID-19), the viral replication phase is often followed by hyperinflammation, which can lead to acute respiratory distress syndrome, multi-organ failure, and death.
Allison Koenecke, Michael Powell, Ruoxuan Xiong, Zhu Shen, Nicole Fischer, Sakibul Huq, Adham M Khalafallah, Marco Trevisan, Pär Sparen, Juan J Carrero, Akihiko Nishimura, Brian Caffo, Elizabeth A Stuart, Renyuan Bai, Verena Staedtke, David L Thomas, Nickolas Papadopoulos, Ken W Kinzler, Bert Vogelstein, Shibin Zhou, Chetan Bettegowda, Maximilian F Konig, Brett D Mensh, Joshua T Vogelstein, Susan Athey   +24 more
doaj   +2 more sources

The efficacy and safety of adrenergic alpha-antagonists combined with PDE5 inhibitors in the medical expulsive therapy for unilateral distal ureteral stones: a systematic review and meta-analysis. [PDF]

Transl Androl Urol
Mo C, Chen C, Fan L, Li J, Fan N, Ning Z, Ding H.   +6 more
europepmc   +2 more sources

The use of alpha-adrenergic antagonists in pediatric nephrolithiasis: a systematic review

Frontiers in Pediatrics
ObjectiveTo evaluate existing clinical evidence for the efficacy of alpha blockers in the management of pediatric stone disease.MethodsWe conducted a systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA ...
Walid Farhat, Firas Haddad
exaly   +3 more sources

Study of the selectivity of alpha(1)-adrenergic antagonists by molecular modeling of alpha(1a)-, alpha(1b)-, and alpha(1d)-adrenergic receptor subtypes and docking simulations

, 2013
Modeling of alpha(1a), alpha(1b), and alpha(1d) adrenergic receptor subtypes has been performed using InsightII software and bovine rhodopsin as a template.
Agbaba, Danica, Zloh, Mire, Solmajer, Tom, Erić, Slavica, Kotnik, Miha   +4 more
core   +6 more sources

Topical administration of adrenergic receptor pharmaceutics and nerve growth factor

Clinical Ophthalmology, 2010
Jena J SteinleDepartments of Ophthalmology and Anatomy and Neurobiology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN 38163, USAAbstract: Topical application of nerve growth factor (NGF) and adrenergic receptor ...
Jena J Steinle
doaj   +1 more source

Medical and non-medical interventions for post-operative urinary retention prevention: network meta-analysis and risk–benefit analysis

Therapeutic Advances in Urology, 2021
Aims: To assess the efficacy in lowering post-operative urinary retention, urinary tract infection and lower urinary tract symptoms and the incidence of adverse events among 12 interventions and to perform risk–benefit analysis.
Pokket Sirisreetreerux, Rujira Wattanayingcharoenchai, Sasivimol Rattanasiri, Oraluck Pattanaprateep, Pawin Numthavaj, Ammarin Thakkinstian   +5 more
doaj   +1 more source

Preventive effects of tamsulosin for postoperative urinary retention after lower limb arthroplasty: A randomized controlled study [PDF]

Investigative and Clinical Urology, 2021
Purpose: This prospective, randomized, controlled study investigated the use of tamsulosin, a selective alpha-blocker, as a prophylactic medication to prevent postoperative urinary retention (POUR) following lower limb arthroplasty.
Chang Il Choi , Jong Keun Kim, Min Soo Choo, Seong Ho Lee, Jun-Dong Chang, Jun Hyun Han   +5 more
doaj   +1 more source